Adobe
By Meghana Keshavan
May 8, 2026
Biotech Correspondent
Meghana Keshavan
A Duchenne therapy lawsuit, FDA Commissioner Marty Makary’s White House troubles, and other news from The Readout
Adobe
By Meghana Keshavan
May 8, 2026
Biotech Correspondent
Meghana Keshavan

Diamantas takes the reins, Regenxbio stakes claim in Duchenne gene therapy, and more biotech news from The Readout

Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout

Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout

A change to FDA clinical trial data review, Rocket sells its priority review voucher, and more biotech news from The Readout

The case for Makary as the WOAT, Cassidy's seat at risk ahead of midterms, and other biotech news from The Readout

A second shot at gene therapy for Huntington's, China's tightening grip on pharma supply chains, and more Readout biotech updates